Empiriko
Advancing Outcomes Through Innovation

Conference: RESI Innovation Challenge

Women CEOs Lead the Day at the RESI Innovation Challenge, Cambridge, MA (March 24, 2014)

Women CEOs Lead the Day at the RESI Innovation Challenge, Cambridge, MA (March 24, 2014)

By Maximilian Klietmann, VP of Marketing, LSN

RESI ended on Monday evening with over 400 attendees and over 660 partnering meetings. Additionally, 33 of the 150 biotech and medtech companies attending RESI were selected for the RESI Innovation Challenge, and competed for “RESI Cash” invested by conference attendees. Well, the winners are in:

  • The winners are global in nature, hailing from the US and Europe.

  • There was a tie for third place.

  • Women led the charge! Three of the four winning companies have women CEOs.

FIRST PLACE:

 
empiriko.png
 

Empiriko, based in Newton, MA, is addressing several of the challenges faced by scientists, clinicians and decision-makers responsible for taking drugs from concept to commercialization. The company’s Biomimiks™ solutions can help in predicting patient/drug interaction and can be used to optimize drug designs, and improve patient outcomes.

Pam Randhawa, Founder and CEO

SECOND PLACE:

BIOARRAY, based in Farmington, CT, is developing proprietary predictive diagnostic tests, based on cancer genes (markers), to choose the most efficacious treatment for cancer patients beforehand, rather than the trial and error approach currently used.

Marcia Fournier, CEO

THIRD PLACE (TIE):

STC Biologics is a biotechnology company located in Cambridge MA focusing on development of biologic drugs. The company’s portfolio of drugs includes a MAb biosimilar for Oncology as well as a re-appropriated biologic drug for the treatment of Alzheimer’s.
Magdalena Leszczyniecka, President and CEO

THIRD PLACE (TIE):

multi.png
 

Multineurons, based in Switzerland, is developing medical devices for non-invasive and wireless brain-computer interface and brain diagnosis/therapy. The company’s products are based on a unique technology that evolved from more than a decade of R&D. 
Tasos Smeros, Founder & CEO

Link to original article

Return to conference listings